Global Biopsy Devices Market Value to Grow Moderately by 2019 with Emerging Countries Increasing the

Reportstack's latest report forecasts that the global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a Compound Annual Growth Rate (CAGR) of 2.93%.
 
 
Spread the Word
Listed Under

Tags:
Vab
Biopsy Devices
Medical Devices
Healthcare
Pharma

Industrys:
Health
Medical

Location:
San Francisco - California - US

Subject:
Products

SAN FRANCISCO - Feb. 25, 2014 - PRLog -- Reportstack’s latest report Biopsy Devices – Global Analysis and Market Forecasts (http://www.reportstack.com/product/150581/biopsy-devices-global-analysis-and-market-forecasts.html), estimates that the biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively. Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the US, reimbursement for image-guided breast biopsies has undergone drastic cuts, which Reportstack expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices.

Joseph Gregory, GlobalData’s Analyst covering Surgical Devices, says: “Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening.” While these challenges are likely to affect the biopsy devices market, GlobalData believes that current and future players can still position themselves to obtain a competitive advantage.

“The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices,” Gregory concludes. Companies mentioned in this report are Argon Medical Devices, Boston Scientific, Cardinal Health, Carefusion Corporation, Cook Medical, C.R.Bard, Devicor Medical Products, DTR Medical, Gallini Medical Devices, Hologic, INRAD, Intact Medical Corporation and TSK Laboratory. The regions covered are US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India. Please visit Biopsy Devices Market (http://www.reportstack.com/product/150581/biopsy-devices-...) report for more details and table of contents.

Contact
Debora White
8887896604
debora@reportstack.com
End
Source:
Email:***@reportstack.com
Posted By:***@reportstack.com Email Verified
Tags:Vab, Biopsy Devices, Medical Devices, Healthcare, Pharma
Industry:Health, Medical
Location:San Francisco - California - United States
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Reportstack PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share